Determination of relevant endpoints to evaluate the in vivo barrier function in cutaneous health

Jornal de Investigação Biomédica e Biofarmacêutica



Bibliographic data

Translated title: Determinação de "endpoints" relevantes para a avaliação in vivo da função "barreira" na saúde cutânea
Journal Title: Jornal de Investigação Biomédica e Biofarmacêutica
First author: Emília Alves
Other Authors: Patrícia Rijo;
Luís Monteiro Rodrigues;
Catarina Rosado
Palabras clave:
Traslated Keywords:
Language: English
Portuguese
Get full text: http://www.alies.pt/BBR%20Editions/Vol-16-1-2019/art9.pdf
Resource type: Journal Article
Source: Jornal de Investigação Biomédica e Biofarmacêutica; Vol 16, No 1 (Year 2019).
DOI: http://dx.doi.org/10.19277/bbr.16.1.201
Publisher: Associação Lusófona para o Desenvolvimento da Investigação e Ensino em Ciências da Saúde
Usage rights: Reconocimiento - NoComercial (by-nc)
Knowledge areas / Categories: Life Sciences --> Biochemistry --AMP-- Molecular Biology
Health Sciences --> Pharmacology --AMP-- Pharmacy
Health Sciences, Life Sciences --> Physiology

Statistical data

  • Views
  • Consultations
  • Citation style
  • Share
  • Export record
  • Favourites

Bibliometric data

WOS

Bibliography: [1] Ritcher T, Peuckert C, Sattler M, et al. Dead but highly dynamic - the Stratum corneum is divided into three hydration zones, Skin Pharmacol Physiol 2004;17: 246-257.

[2] Proksch E, Fölster-Holst R, Bräutigam M, et al. Role of the epidermal barrier in atopic dermatitis. J Dtsch Dermatol Ges 2009; 10: 899-910.

[3] Chilcott, RP, Dalton, CH, Emmanuel, AJ, et al..Transepidermal water loss does not correlate with skin barrier function in vitro, J Invest Dermatol 2002; 118: 871-875.

[4] Polańska A, Dańczak-Pazdrowska A, Silny W, et al. Evaluation of selected skin barrier functions in atopic dermatitis in relation to the disease severity and pruritus. Postep Derm Alergol 2012; 29: 373-377.

[5] Polańska A, Dańczak-Pazdrowska A, Silny W, et al. Nonlesional skin in atopic dermatitis is seemingly healthy skin - observations using noninvasive methods. Wideochir Inne Tech Maloinwazyjne 2013; 8(3):192–199.

[6] Kim BE, Leung DYM. Significance of Skin Barrier Dysfunction in Atopic Dermatitis. Allergy Asthma Immunol Res. 2018; 10(3): 207-215.

[7] Frosch PJ, Wissing C. Cutaneous sensitivity to ultraviolet light and chemical irritants. Arch Dermatol Res 1982;272(3-4):269-278.

[8] Rosado C, Ferreira J, Pinto PC, Rodrigues LM. Skin Barrier Function Evaluation by Bi-compartmental Analisys of TEWL Dynamical Measurements: Validation of New Analytical Conditions. Biomed Biopharm Res 2012; (9) 2: 183-189

[9] Kim DW, Park JY, Na GY, Lee SJ, Lee WJ. Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis. Int J Dermatology 2006: 45, 698–701.

[10] Belsito, DV. Occupational contact dermatitis: etiology, prevalence, and resultant impairment/disability. J Am Acad Dermatol 2005; 53: 303-313.

[11] Wahlberg JE, Maibach HI. Nonanoic acid irritation – a positive control at routine patch testing. Contact Dermatitis 1980; 6:128-130.

[12] Held E, Agner T. Comparison between 2 test models in evaluating the effect of a moisturizer on irritated human skin. Contact Dermatitis 1999; 40: 261–268.

[13] Rogiers V. EEMCO guidance for the Assessment of the Transepidermal Water Loss (TEWL) in Cosmetic Sciences. Skin Pharmacol Physiol 2001; 14:117-128.

[14] Gloor M, Senger B, Langenauer M, et al.. On the course of the irritant reaction after irritation with sodium lauryl sulphate. Skin Res Technol 2004; 10: 144-148.

[15] Bircher AJ, de Boer EM, Agner T, Wahlberg JE, et al. Guidelines for the measurement of cutaneous blood flow by laser Doppler flowmetry. Contact Dermatitis 1994; 30:65-72.

[16] Fullerton AQ, Fisher T, Lahti, AQ, et al. Guidelines for the measurement of skin color and erythema, Contact Dermatitis 1996; 35:1-10.

[17] de Oliveira CA, Peres DD, Rugno CM, Kojima M, de Oliveira Pinto C.S, Consiglieri VO, Kaneko TM, Rosado C, Mota J, Velasco MVR, Baby AR. Functional photostability and cutaneous compatibility of bioactive UVA sun care products. J Photochem Photobiol B Biol 2015;148:154-159.

[18] Pinnagoda J, Tupker R A, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurements. Contact Dermatitis 1990; 22: 164–178.

[19] Thomas CL, Fernández-Peñas P. The microbiome and atopic eczema: More than skin deep. Australas. J Dermatol 2017; 58:18–24.

[20] Makrgeorgou A, Leonardi-Bee J, Bath-Hextall FJ, Murrell DF, Tang ML, Roberts A, Boyle RJ. Probiotics for treating eczema. Cochrane database Syst. Rev. 2018. 11, CD006135.

[21] Aramaki J, Effendy I, Happle R, et al. Which bioengineering assay is appropriate for irritant patch testing with sodium lauryl sulfate? Contact Dermatitis 2001; 45:286-290.

[22] Jakasa I, de Jongh CM, Verberk MM, Bos JD, Kezic S. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of atopic dermatitis patients compared to control subjects. Br J Dermatol 2006; 155:104–109.

[23] Bandier J, Carlsen BC, Rasmussen MA, Petersen LJ, Johansen JD. Skin reaction and regeneration after single sodium lauryl sulfate exposure stratified by filaggrin genotype and atopic dermatitis phenotype. Br J Dermatol 2015; 172: 1519–1529.

[24] Angelova-Fischer I, Dapic I, Hoek AK, Jakasa I, Fischer TW, Zillikens D, Kezic S. Skin barrier integrity and natural moisturising factor levels after cumulative dermal exposure to alkaline agents in atopic dermatitis. Acta Derm Venereol 2014; 94: 640–644.